Skip to main content

Table 4 Multivariate COX regression for prognostic features of gastric cancer patients

From: Multivariate analysis of clinicopathological and prognostic significance of miRNA 106b~25 cluster in gastric cancer

FeaturesβSEWalddfPHR (95% CI)
T stage
 T1, T2− 0.9160.3417.22910.0070.400 (0.205–0.780)
 T3, T4      
N stage
 N00.6120.7140.73410.3921.844 (0.455–7.470)
TNM stage
 I, II0.7030.4462.48510.1152.019 (0.843–4.839)
 III, IV      
Tumor size
 < 50.8320.4942.83910.0922.297 (0.873–6.042)
 > 5      
Plasma miR 106b
 Low− 0.9900.4894.09910.0430.371 (0.142–0.969)
Plasma miR 93
 Low− 0.1250.4030.09610.7570.882 (0.400–1.946)
Plasma miR 25
 Low0.5550.4071.86110.1721.742 (0.785–3.866)
Tumor miR 106b
 Low0.2200.3770.34010.5601.246 (0.595–2.612)
Tumor miR 93
 Low− 1.2200.4039.16210.0020.295 (0.134–0.650)
Tumor miR 25
 Low− 0.0290.4770.00410.9510.971 (0.381–2.473)
  1. To get adjusted hazard ratios, COX regression was applied for adjusting significant covariate in Kaplan–Meier prognostic analysis
  2. β regression coefficient, SE standard error, Wald wald Chi square; df degree of freedom, HR hazard ratio